Left ventricular assist device: A functional comparison with heart transplantation

Netherlands Heart Journal

Volumn 16, Issue 2, 2008, Pages 41-46

  Pruijsten, R V ^a   De Jonge, N ^a   Kirkels, J H ^a   Klopping C ^a   Doevendans, P A F M ^a   Oosterom, A ^a   Kemperman, H ^a   Lahpor, J R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Heart failure; Heart transplantation; Ventricular assist device

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

ARTICLE; ASSISTED CIRCULATION; CONVALESCENCE; CREATININE BLOOD LEVEL; EXERCISE; HEART ASSIST DEVICE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; OXYGEN TRANSPORT; PROTEIN BLOOD LEVEL; TREATMENT INDICATION;

EID: 38949142363     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086116     Document Type: Article

References (21)

1. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
2. Jaski BE, Lingle RJ, Kim J, Branch KR, Goldsmith R, Johnson MR, et al. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. J Heart Lung Transplant 1999;18:1031-40.
3. Chatterjee K. Refractory heart failure - drugs and devices. Eur Heart J 2001;22:2227-30.
4. Oosterom A, de Jonge N, Kirkels JH, Rodermans BF, Sukkel E, Klöpping C, et al. End-stage heart failure and mechanical circulatory support: feasibility of discharge from hospital. Neth Heart J 2007;15:45- 50.
5. Lahpor JR, de Jonge N, van Swieten HA, Wesenhagen H, Klöpping C, Geertman JH, et al. Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure. Neth Heart J 2002;10:267-71.
6. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
7. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
8. Kemperman H, Van den Berg M, Kirkels H, De Jonge N. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem 2004;50:1670-2.
9. Sodian R, Loebe M, Schmitt C, Potapov EV, Siniawski H, Muller J, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 2001;38:1942-9.
10. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
11. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-9.
12. Jones NL, Campbell EJM, Edwards RHT, Robertson DG. Clinical exercise testing. Philadelphia: WB Saunders, 1975:202.
13. De Jonge N, Kirkels JH, Lahpor JR, Klöpping C, Hulzebos EJ, de la Rivière AB, et al. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation; an outlook for permanent assisting? J Am Coll Cardiol 2001;37:1794-9.
14. Kao AC, Van Trigt P, Shaeffer-McCall GS, Shaw JP, Kuzil BB, Page RD, et al. Allograft diastolic dysfunction and chronotropic incompetence limit cardiac output response to exercise two to six years after heart transplantation. J Heart Lung Transplant 1995;14:11-22.
15. Minotti JR, Johnson EC, Hudson TL, Zuroske G, Murata G, Fukushima E, et al. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990;86:751-8.
16. Adamopoulos S, Coats AJ, Brunotte F, Arnolda L, Meyer T, Thompson CH, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 1993;21:1101-6.
17. Hambrecht R, Niebauer J, Fiehn E, Kalberer B, Offner B, Hauer K, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995;25:1239-49.
18. Robbins M, Francis G, Pashkow FJ, Snader CE, Hoercher K, Young JB, et al. Ventilatory and heart rate responses to exercise: better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999;100:2411-7.
19. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90.
20. Stevenson LW, Shekar P. Ventricular assist devices for durable support. Circulation 2005;112:e111-5.
21. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.